Anne Sofie Astrup

1.3k total citations
20 papers, 956 citations indexed

About

Anne Sofie Astrup is a scholar working on Cardiology and Cardiovascular Medicine, Nephrology and Endocrinology, Diabetes and Metabolism. According to data from OpenAlex, Anne Sofie Astrup has authored 20 papers receiving a total of 956 indexed citations (citations by other indexed papers that have themselves been cited), including 10 papers in Cardiology and Cardiovascular Medicine, 7 papers in Nephrology and 4 papers in Endocrinology, Diabetes and Metabolism. Recurrent topics in Anne Sofie Astrup's work include Chronic Kidney Disease and Diabetes (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Anne Sofie Astrup is often cited by papers focused on Chronic Kidney Disease and Diabetes (7 papers), Blood Pressure and Hypertension Studies (6 papers) and Cardiovascular Function and Risk Factors (5 papers). Anne Sofie Astrup collaborates with scholars based in Denmark, United States and Netherlands. Anne Sofie Astrup's co-authors include Lise Tarnow, Peter Rossing, Hans‐Henrik Parving, Lotte Pietraszek, Peter Riis Hansen, Maria Lajer, Hans‐Henrik Parving, K. J. Schjoedt, Birgitte V. Hansen and J. Hilsted and has published in prestigious journals such as Circulation, PLoS ONE and The Journal of Clinical Endocrinology & Metabolism.

In The Last Decade

Anne Sofie Astrup

20 papers receiving 936 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Anne Sofie Astrup Denmark 14 333 276 228 220 123 20 956
M.-A. Gall Denmark 11 374 1.1× 320 1.2× 342 1.5× 104 0.5× 125 1.0× 12 878
Simone Theilade Denmark 17 446 1.3× 219 0.8× 167 0.7× 122 0.6× 147 1.2× 51 960
Marie Frimodt‐Møller Denmark 18 276 0.8× 342 1.2× 200 0.9× 181 0.8× 143 1.2× 60 947
Francesco Frigato Italy 12 351 1.1× 463 1.7× 578 2.5× 88 0.4× 101 0.8× 20 1.0k
B. O. Boehm Germany 13 154 0.5× 353 1.3× 121 0.5× 129 0.6× 41 0.3× 28 795
Afshin Parsa United States 20 308 0.9× 106 0.4× 375 1.6× 111 0.5× 137 1.1× 34 1.3k
K. Py�r�l� Finland 9 300 0.9× 456 1.7× 83 0.4× 157 0.7× 89 0.7× 13 774
Susanne Bro Denmark 16 196 0.6× 119 0.4× 653 2.9× 257 1.2× 57 0.5× 43 1.0k
Cinzia Carrozza Italy 20 227 0.7× 667 2.4× 297 1.3× 570 2.6× 118 1.0× 53 1.2k
Elise Gand France 15 146 0.4× 226 0.8× 251 1.1× 151 0.7× 81 0.7× 35 675

Countries citing papers authored by Anne Sofie Astrup

Since Specialization
Citations

This map shows the geographic impact of Anne Sofie Astrup's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Sofie Astrup with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Sofie Astrup more than expected).

Fields of papers citing papers by Anne Sofie Astrup

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Sofie Astrup. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Sofie Astrup. The network helps show where Anne Sofie Astrup may publish in the future.

Co-authorship network of co-authors of Anne Sofie Astrup

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Sofie Astrup. A scholar is included among the top collaborators of Anne Sofie Astrup based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Sofie Astrup. Anne Sofie Astrup is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Astrup, Anne Sofie, et al.. (2014). [Pseudoaneurysm in the subclavian artery as a long-term complication to clavicula fracture].. PubMed. 176(49). 1 indexed citations
2.
Reinhard, Henrik, Peter Karl Jacobsen, Maria Lajer, et al.. (2011). Endothelial Progenitor Cells in Long-Standing Asymptomatic Type 1 Diabetic Patients with or without Diabetic Nephropathy. Nephron Clinical Practice. 118(3). c309–c314. 7 indexed citations
3.
Astrup, Anne Sofie. (2011). Cardiovascular morbidity and mortality in diabetes mellitus: prediction and prognosis.. PubMed. 58(8). B4152–B4152. 12 indexed citations
4.
Nielsen, Stine E., K. J. Schjoedt, Anne Sofie Astrup, et al.. (2010). Neutrophil Gelatinase‐Associated Lipocalin (NGAL) and Kidney Injury Molecule 1 (KIM1) in patients with diabetic nephropathy: a cross‐sectional study and the effects of lisinopril. Diabetic Medicine. 27(10). 1144–1150. 119 indexed citations
5.
Astrup, Anne Sofie, Lise Tarnow, Anders Jorsal, et al.. (2009). Telomere length predicts all-cause mortality in patients with type 1 diabetes. Diabetologia. 53(1). 45–48. 70 indexed citations
6.
Lund, Søren S., Lise Tarnow, Anne Sofie Astrup, et al.. (2009). Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes. Diabetes Obesity and Metabolism. 11(10). 966–977. 41 indexed citations
7.
Nielsen, Stine E., Takeshi Sugaya, Lise Tarnow, et al.. (2009). Tubular and Glomerular Injury in Diabetes and the Impact of ACE Inhibition. Diabetes Care. 32(9). 1684–1688. 66 indexed citations
8.
Lund, Søren S., Lise Tarnow, Anne Sofie Astrup, et al.. (2008). Effect of Adjunct Metformin Treatment in Patients with Type-1 Diabetes and Persistent Inadequate Glycaemic Control. A Randomized Study. PLoS ONE. 3(10). e3363–e3363. 70 indexed citations
9.
Schjoedt, K. J., Anne Sofie Astrup, Frederik Persson, et al.. (2008). Optimal dose of lisinopril for renoprotection in type 1 diabetic patients with diabetic nephropathy: a randomised crossover trial. Diabetologia. 52(1). 46–49. 24 indexed citations
10.
Astrup, Anne Sofie, Won Yong Kim, Lise Tarnow, et al.. (2008). Relation of Left Ventricular Function, Mass, and Volume to NT-proBNP in Type 1 Diabetic Patients. Diabetes Care. 31(5). 968–970. 4 indexed citations
11.
Joseph, Gowsini, Lise Tarnow, Anne Sofie Astrup, et al.. (2008). Plasma α-Defensin Is Associated with Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients. The Journal of Clinical Endocrinology & Metabolism. 93(4). 1470–1475. 36 indexed citations
12.
Astrup, Anne Sofie, Lise Tarnow, Lotte Pietraszek, et al.. (2008). Markers of Endothelial Dysfunction and Inflammation in Type 1 Diabetic Patients With or Without Diabetic Nephropathy Followed for 10 Years. Diabetes Care. 31(6). 1170–1176. 99 indexed citations
13.
Astrup, Anne Sofie, Lise Tarnow, Michael Christiansen, et al.. (2007). Pregnancy‐associated plasma protein A in a large cohort of Type 1 diabetic patients with and without diabetic nephropathy—a prospective follow‐up study. Diabetic Medicine. 24(12). 1381–1385. 12 indexed citations
14.
Astrup, Anne Sofie, F. S. Nielsen, Peter Rossing, et al.. (2007). Predictors of mortality in patients with type 2 diabetes with or without diabetic nephropathy: a follow-up study. Journal of Hypertension. 25(12). 2479–2485. 76 indexed citations
15.
Kim, Won Yong, Anne Sofie Astrup, Matthias Stuber, et al.. (2006). Subclinical Coronary and Aortic Atherosclerosis Detected by Magnetic Resonance Imaging in Type 1 Diabetes With and Without Diabetic Nephropathy. Circulation. 115(2). 228–235. 88 indexed citations
16.
Astrup, Anne Sofie, Lise Tarnow, Peter Rossing, et al.. (2006). Cardiac Autonomic Neuropathy Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients With Diabetic Nephropathy. Diabetes Care. 29(2). 334–339. 134 indexed citations
17.
Astrup, Anne Sofie, Lise Tarnow, Peter Rossing, et al.. (2005). Improved prognosis in type 1 diabetic patients with nephropathy: A prospective follow-up study. Kidney International. 68(3). 1250–1257. 58 indexed citations
18.
Tarnow, Lise, Anne Sofie Astrup, & Hans‐Henrik Parving. (2005). Elevated Placental Growth Factor (PlGF) Predicts Cardiovascular Morbidity and Mortality in Type 1 Diabetic Patients with Diabetic Nephropathy. Scandinavian Journal of Clinical and Laboratory Investigation. 65(sup240). 73–79. 15 indexed citations
19.
Rossing, Peter, Anne Sofie Astrup, U. Smidt, & H.‐H. Parving. (1994). Monitoring kidney function in diabetic nephropathy. Diabetologia. 37(7). 708–712. 1 indexed citations
20.
Rossing, Peter, Anne Sofie Astrup, U. Smidt, & Hans‐Henrik Parving. (1994). Monitoring kidney function in diabetic nephropathy. Diabetologia. 37(7). 708–712. 23 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by M.-A. Gall Breakdown of academic impact, for papers by Simone Theilade Breakdown of academic impact, for papers by Marie Frimodt‐Møller Breakdown of academic impact, for papers by Francesco Frigato Breakdown of academic impact, for papers by B. O. Boehm Breakdown of academic impact, for papers by Afshin Parsa Breakdown of academic impact, for papers by K. Py�r�l� Breakdown of academic impact, for papers by Susanne Bro Breakdown of academic impact, for papers by Cinzia Carrozza Breakdown of academic impact, for papers by Elise Gand
Rankless by CCL
2026